The World Health Organization (WHO) has said AstraZeneca COVID-19 vaccine was temporarily suspended by some countries in the European Union (EU) as a precautionary measure.
It said the countries suspended the vaccines due to reports of rare blood coagulation disorders in persons who had received the vaccine.
The health body which recommended the vaccine said that some countries in the EU, having considered the same information, had decided to continue using the vaccine.
WHO explained that it has considered the benefits of the AstraZeneca vaccine and it outweighed its risks.
“Vaccination against COVID-19 will not reduce illness or deaths from other causes. Thromboembolic events are known to occur frequently. Venous thromboembolism is the third most common cardiovascular disease globally